Laxative Sennosides, 25 mg 25 mg Tablet, Film Coated, 90-count
by Granulation Technology, Inc. · 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63561-0186-9)
NDC 63561-0186-09
🏷️ FDA NDC (as labeled)
63561-0186-9
billing pads the package segment with a zero
This package
Contains90-count
Pack sizes2 compare ↓
Also comes in:
1000 tablets 63561-0186-02
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
63561-0186-9
Product NDC
63561-0186
11-digit billing NDC
63561018609
RxCUI
251292
UNII
3FYP5M0IJX
UPC
0363561018625
Application #
505G(a)(3)
SPL Set ID
f7e2010c-8f59-4d70-b25a-f7f0a72011ef
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2025-06-11
Route
ORAL
Dosage form
TABLET, FILM COATED
Substance
SENNOSIDES
Why two NDCs?
The FDA registers this code as 63561-0186-9 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 63561-0186-09. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Contact laxatives class.
Drug family (ATC)
Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerGranulation Technology, Inc.
FDA application505G(a)(3) (OTC MONOGRAPH DRUG)
Labeler code63561
First marketedJun 2025
Product typeHuman Otc Drug
Portfolio16 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
- How long does it take for senna to work?
- Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
- Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Sennosides, 25 mg?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
blue
ShapeRound
ImprintG186
Size1 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
1000 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Maximum Strength Laxative 25 mg 70000-0077-01 | CARDINAL | 24 tablets | $0.116 | — | Availability likely | — |
| Ex-Lax Maximum Strength Stimulant Laxative 25 mg 00067-8142-01 | Haleon | 12 pills | — | — | FDA listed | — |
| Laxative 25 mg 00363-9978-24 | WALGREENS | 24 tablets | — | — | FDA listed | — |
| Maximum Strength Laxative Pills 25 mg 11673-0995-48 | TARGET | 48 tablets | — | — | FDA listed | — |
| Laxative 25 mg 11822-0773-08 | Rite | 12 tablets | — | — | FDA listed | — |
| Laxative 25 mg 21130-0591-24 | BETTER | 24 tablets | — | — | FDA listed | — |
| HEB Maximum strength Laxative pills 25 mg 37808-0149-12 | H | 24 tablets | — | — | FDA listed | — |
| Maximum Strength Laxative 25 mg 41226-0195-24 | Kroger | 24 tablets | — | — | FDA listed | — |
| Publix Laxative Maximum Strength 25 mg 41415-0114-24 | PUBLIX | 24 tablets | — | — | FDA listed | — |
| Lax-Time 25 mg 49483-0083-00 | TIME | 50000 tablets | — | — | FDA listed | — |
| Laxative 25 mg 50844-0773-08 | L.N.K. | 12 tablets | — | — | FDA listed | — |
| Laxative 25 mg 55301-0773-08 | ARMY | 12 tablets | — | — | FDA listed | — |
| Laxative 25 mg 55319-0773-08 | Family | 12 tablets | — | — | FDA listed | — |
| Laxative 25 mg 55910-0454-08 | DOLGENCORP, | 12 tablets | — | — | FDA listed | — |
| Laxative 25 mgthis 63561-0186-09 | Granulation | 90 tablets | — | — | FDA listed | — |
| Laxative 25 mg 63941-0073-08 | Valu | 12 tablets | — | — | Discontinued | — |
| Maximum Strength Laxative 25 mg 69842-0195-09 | CVS | 90 tablets | — | — | FDA listed | — |
| Maximum Strength Senna Laxative 25 mg 72090-0016-01 | Pioneer | 100 tablets | — | — | FDA listed | — |
| Laxative 25 mg 76162-0773-08 | TOPCO | 12 tablets | — | — | FDA listed | — |
| Laxative 25 mg 79481-7730-02 | Meijer | 12 tablets | — | — | FDA listed | — |
| Laxative 25 mg 79903-0096-08 | WALMART | 24 tablets | — | — | FDA listed | — |
| Maximum Strength Senna Laxative 25 mg 84324-0033-01 | NUVICARE | 60 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2025
On the market since
Jun 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Bisacodyl — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 43%
Female · 57%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 63561-0186-02 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63561-0186-2) | 2025-07-29 | Active |
| 63561-0186-09 You're viewing this | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63561-0186-9) | 2025-06-11 | Active |
You're viewing the smallest of 2 pack sizes for this product.
Pack size FAQ
What quantity is in NDC 63561-0186-09?
NDC 63561-0186-09 is a 90-count package — 90 tablet, film coated in 1 bottle, plastic.
What is the difference between NDC 63561-0186-09 and NDC 63561-0186-02?
Both are Laxative Sennosides, 25 mg 25 mg Tablet, Film Coated — the drug itself is identical. NDC 63561-0186-09 is the 90-count package, while NDC 63561-0186-02 is the 1000 tablets package.
What NDC number is used to bill for this package of Laxative Sennosides, 25 mg 25 mg Tablet, Film Coated?
Bill NDC 63561-0186-09 — the 11-digit billing format is 63561018609. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 63561-0186-9, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 63561-0186-09, written without dashes as 63561018609. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 63561-0186-09, the first segment (63561) is the labeler code FDA assigned to Granulation Technology, Inc.; the middle segment (0186) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (09) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Granulation Technology, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1000 tablets (63561-0186-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Granulation Technology, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses Relieves occasional constipation (irregularity) Generally produces a bowel movement in 6-12 hours
⏱️ Dosage and Administration ▾
Directions swallow tablet (s) with a glass of water. swallow tablet (s) whole, do not crush, break, or chew. Age Dosage adults and children 12 years of age and over 2 tablets once or twice daily children 6 to under 12 years 1 tablet once a day or twice daily children under 6 years Ask a doctor
⚠️ Warnings ▾
Warnings
📦 Storage and Handling ▾
Other information Each tablet contains: Calcium 40 mg, Magnesium 5 mg Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) Use by expiration date on package
🧪 Active Ingredient ▾
Active ingredient (in each tablet) Sennosides, 25 mg
🧪 Inactive Ingredients ▾
Inactive ingredients croscarmellose sodium, dibasic calcium phosphate dihydrate, microcrystalline cellulose, pregelatinized starch, colloidal silicon dioxide, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol (PEG) 3350, talc, yellow iron oxide, FD&C blue 1 lake
🎯 Purpose ▾
Purpose Stimulant Laxative
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.